$10.44
+0.00 (+0.00%)
Open$10.45
Previous Close$10.44
Day High$10.46
Day Low$10.44
52W High$10.65
52W Low$10.11
Volume—
Avg Volume44.0K
Market Cap391.70M
P/E Ratio38.73
EPS$0.50
SectorN/A
Analyst Ratings
Sell
9 analysts
Price Target
+218.5% upside
Current
$10.44
$10.44
Target
$33.25
$33.25
$21.69
$33.25 avg
$38.82
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 229.75M | 221.12M | 203.42M |
| Net Income | 18.67M | 19.49M | 13.94M |
| Profit Margin | 8.1% | 8.8% | 6.9% |
| EBITDA | 31.30M | 28.96M | 26.35M |
| Free Cash Flow | 15.11M | 9.40M | 12.42M |
| Rev Growth | +0.0% | -7.2% | +5.6% |
| Debt/Equity | 0.24 | 0.28 | 0.30 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.9 | 595.50M |